PARP1 and lung carcinoma: In addition, we examined the impact of TLS factors on sensitivity to PARP inhibitor in the lung cancer cells, and fond that knockdown of the four TLS factors slightly enhanced sensitivity of A549/DR and A549 cells to BMN (Figure 3D and 3E).